Uncategorized Hortons Pharmacy Eli Lilly, a major pharmaceutical company, is investing $27 billion to build four new manufacturing plants in the United States. This move shows their commitment to increasing drug production in the country. Some of the well-known medications they make include Trulicity for diabetes and Taltz for psoriasis. Mar 18, 2025
Uncategorized Hortons Pharmacy Eli Lilly, a major pharmaceutical company, has paid $10 million in advance to collaborate with Organovo, another biotech company, on developing a new drug known as an FXR agonist. This type of drug could potentially help with liver diseases. Specific pill names related to this drug haven’t been mentioned yet. Mar 15, 2025
Uncategorized Hortons Pharmacy RedHill and Hyloris have teamed up to develop a medication called Bekinda. Mar 12, 2025
Uncategorized Hortons Pharmacy Idorsia’s deal with Tryvio has fallen through, putting the company in a tight spot financially. Now, Idorsia urgently needs to find new sources of funding. Some of the medications associated with Idorsia include clazosentan and daridorexant. Mar 09, 2025
Uncategorized Hortons Pharmacy Emalex is seeking approval from the FDA for a new treatment for Tourette syndrome after successful results in their Phase III clinical trials. This means they are one step closer to making the treatment available to the public. Some medications often used for Tourette syndrome include haloperidol and pimozide, but the name of Emalex’s specific drug wasn’t mentioned in your text. Mar 06, 2025
Uncategorized Hortons Pharmacy Eikon, a company focused on cancer treatments, has raised nearly $351 million to help develop and test its cancer drugs in clinical trials. However, the specific names of the drugs are not mentioned in the text provided. Mar 03, 2025
Uncategorized Hortons Pharmacy Eli Lilly is planning to increase its pharmaceutical production in the United States by building four new facilities. This expansion could involve the production of well-known medications like Trulicity and Jardiance. Feb 28, 2025
Uncategorized Hortons Pharmacy The FDA has given fast track status to Pyxis’ drug, PYX-201. This means the approval process for PYX-201 will be sped up because it shows promise in treating a serious condition. However, the text does not mention any specific pill names related to PYX-201. Feb 25, 2025
Uncategorized Hortons Pharmacy Regeneron is trying again to get approval for its blood cancer treatment. If possible, please include the names of some medications in the explanation. Feb 22, 2025
News Hortons Pharmacy How pharmaceutical companies can use print materials to stay flexible and competitive. Dec 04, 2024Dec 20, 2024